95 results
DEFM14A
CYCN
Cyclerion Therapeutics Inc
20 Jun 23
Proxy related to merger
4:55pm
the Purchased Programs and all related historical safety and pharmacovigilance data, provided that Cyclerion will have the right to make copies of all … Governmental Entity regarding the Purchased Programs, all preclinical and clinical study data supporting the Purchased Programs and all related historical safety
PREM14A
rrmu8q
9 Jun 23
Preliminary proxy related to merger
5:23pm
8-K
EX-99.1
owjne 2ocjhcdbj
15 May 23
Cyclerion Announces Reverse Stock Split
5:02pm
DEFA14A
xc11wx
11 May 23
Additional proxy soliciting materials
7:28pm
8-K
EX-99.2
mz9in4g6
11 May 23
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
7:26pm
8-K
EX-2.1
lb6aw
11 May 23
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
7:26pm
8-K
EX-99.1
g7p859
11 May 23
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
7:26pm
8-K
EX-99.1
y36lul
22 Nov 22
Cyclerion Concludes Unsolicited Proposal Is Not in The Best Interest of The Company
4:31pm
8-K
EX-99.1
u9x1ebx uahvc3pxfo5w
6 Oct 22
Cyclerion Announces Mitochondrial Disease-Focused Corporate Strategy
8:01am
8-K
EX-99.1
0djs gdocm0
28 Jul 22
Cyclerion Therapeutics Announces Positive Topline Clinical Data for CY6463 in
9:00am
8-K
EX-99.2
ypg5ime 36zu
28 Jul 22
Cyclerion Therapeutics Announces Positive Topline Clinical Data for CY6463 in
9:00am
8-K
EX-99.1
5d7rj 5fu6qmfnxcuq
10 Jun 22
Cyclerion Therapeutics Announces Positive Topline Clinical Data for CY6463 in MELAS Patients at UMDF Mitochondrial Medicine 2022 Symposium
7:01am
8-K
EX-99.2
g2rxht5t48v9l6f
10 Jun 22
Cyclerion Therapeutics Announces Positive Topline Clinical Data for CY6463 in MELAS Patients at UMDF Mitochondrial Medicine 2022 Symposium
7:01am